CAS 916591-01-0

(4S,7R)-1-(2,4-Difluorophenyl)-N-(1,1-dimethylethyl)-4,5,6,7-tetrahydro-4,7-methano-1H-indazole-3-carboxamide

Formula: C₁₉H₂₁F₂N₃O

InChI: InChI=1S/C19H21F2N3O/c1-19(2,3)22-18(25)16-15-10-4-5-11(8-10)17(15)24(23-16)14-7-6-12(20)9-13(14)21/h6-7,9-11H,4-5,8H2,1-3H3,(H,22,25)/t10-,11+/m0/s1

InChI key: InChIKey=NTPZXHMTJGOMCJ-WDEREUQCSA-N

SMILES: C(NC(C)(C)C)(=O)C=1C2=C(N(N1)C3=C(F)C=C(F)C=C3)[C@]4(C[C@@]2(CC4)[H])[H]

Synonyms:

• (4S,7R)-1-(2,4-Difluorophenyl)-N-(1,1-dimethylethyl)-4,5,6,7-tetrahydro-4,7-methano-1H-indazole-3-carboxamide
• Tedalinab
• 4,7-Methano-1H-indazole-3-carboxamide, 1-(2,4-difluorophenyl)-N-(1,1-dimethylethyl)-4,5,6,7-tetrahydro-, (4S,7R)-

Tedalinab

CAS: 916591-01-0

Tedalinab

Formula: C₁₉H₂₁F₂N₃O

Purity: ≥95%

Molecular weight: 345.39

Ref: 54-PC1028918

Tedalinab

CAS: 916591-01-0

Formula: C₁₉H₂₁F₂N₃O

Purity: 99.94%

Color and Shape: Solid

Molecular weight: 345.3863

Ref: IN-DA01E5T3

Tedalinab

Controlled Product

CAS: 916591-01-0

Applications Tedalinab is a cannabinoid receptor modulator that is useful for treating non-immediate type allergic diseases.
References Muthuppalaniappan, M., et al.: PCT Int. Appl. WO 2006129178 A1 20061207. Dec 7, 2006; Narayanan, S., et al.: U.S. Pat. Appl. Publ. US 20090312385 A1 20091217. Dec 17, 2009

Formula: C₁₉H₂₁F₂N₃O

Color and Shape: Neat

Molecular weight: 345.39

Ref: TR-T013730

Tedalinab-d9

Controlled Product

CAS: 916591-01-0

Formula: C₁₉D₉H₁₂F₂N₃O

Color and Shape: Neat

Molecular weight: 354.442

Ref: TR-T013732

Tedalinab

CAS: 916591-01-0

Tedalinab is a selective CB2 agonist used in cannabinoid signaling, immune modulation, and pain-related neuroimmune research.

Formula: C₁₉H₂₁F₂N₃O

Purity: 98%

Color and Shape: Solid

Molecular weight: 345.3863

Ref: TM-T17027